Skip to main content

The Implementation of a Novel Kidney Function Biomarker in Clinical Routine

Speaker: Univ.-Prof. Dr. med. Gernot Marx, University Hospital RWTH Aachen, Germany

Even though AKI affects 1 in 3 patients in the intensive care units, there is a significant unmet need generated by late and unspecific standard diagnostic tools. With the goal of obtaining a more prompt and precise detection of worsening and improvement of kidney function, the Clinic for Operative Intensive Care and Intermediate Care at University Hospital RWTH Aachen has implemented an innovative biomarker in the clinical routine.

Prof. Dr. Gernot Marx discusses the change in practice needed to implement the kidney function biomarker Proenkephalin A 119-159 (penKid) in the daily routine. He will also approach the clinical applications where penKid shows potential to improve patient management.

Learn more about the speaker

Prof. Dr. Gernot Marx, MD, FRCA is full Professor of Anesthesiology and Critical Care Medicine and Chair at the University RWTH Aachen, Germany. He is Head of the Department of Intensive Care Medicine and Intermediate Care at the University Hospital RWTH Aachen. He is former president of the interdisciplinary German Society of Intensive Care and Emergency Medicine (DIVI). He is full board member of the German Society of Anaesthesia and Intensive Care. He is involved in the German initiative of Medical Informatics as well as several EU funded projects (SMART4Health & ICU4Covid). In 2018 he was elected as chair of Innovation centre for digital medicine in Aachen.

He graduated and took his residency at the Medizinische Hochschule Hannover in Germany. He was Senior Lecturer in Anaesthesia and Intensive Care Medicine at the University of Liverpool, UK and full Professor for Anaesthesiology, Intensive Care and Emergency Medicine at the Friedrich-Schiller-Universität Jena, Germany. He received the Fellowship by election of the Royal College of Anaesthetists. His research interest is focused on sepsis, AI and telemedicine. Prof. Marx has published more than 200 peer-reviewed papers. He is Editor of various books and Editor in Chief of intensivup2date. In 2021 he received the national prize for patient safety for his telemedicine projects.


Fill in the form to watch the webinar on demand

Watch other webinars on demand


Acute Heart Failure

Using bio-ADM and penKid for Optimization of AHF Management in Daily Clinical Practice

Speaker: Prof. John Parissis MD, PhD, Attikon General Hospital, Head of University Clinic of Emergency Medicine, University of Athens, Greece


Glomerular Filtration Rate

Using Proenkephalin as a Novel Biomarker to Estimate GFR

Speaker: Prof. Dr. Peter Pickkers, Professor of Intensive Care Medicine at the Radboud University Medical Center Nijmegen, the Netherlands


Acute Kidney Injury

Overcoming the Limitations of Acute Kidney Injury (AKI) Diagnostics in the Emergency Department: the Biomarker Proenkephalin for Early Recognition of AKI

Speaker: Prof. Salvatore Di Somma, MD PhD; University La Sapienza Rome


The information presented on the webinar(s) is meant for healthcare professionals only. The information provided does not claim to be exhaustive and is not intended to serve as medical advice, substitute for a doctor’s appointment, or be used for diagnosing or treating a disease.